Page last updated: 2024-10-26

dipyridamole and Myeloproliferative Disorders

dipyridamole has been researched along with Myeloproliferative Disorders in 3 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Myeloproliferative Disorders: Conditions which cause proliferation of hemopoietically active tissue or of tissue which has embryonic hemopoietic potential. They all involve dysregulation of multipotent MYELOID PROGENITOR CELLS, most often caused by a mutation in the JAK2 PROTEIN TYROSINE KINASE.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Meschengieser, SS1
Woods, AI1
Schattner, MA1
Lazzari, MA1
Luzzatto, G1
Fabris, F1
Mazzucato, M1
Girolami, A1
Niikura, H1

Reviews

1 review available for dipyridamole and Myeloproliferative Disorders

ArticleYear
[Thrombosis in various diseases: myeloproliferative disorders].
    Nihon rinsho. Japanese journal of clinical medicine, 1986, Volume: 44, Issue:5

    Topics: Aspirin; beta-Thromboglobulin; Blood Coagulation Factors; Busulfan; Carbazilquinone; Dipyridamole; H

1986

Other Studies

2 other studies available for dipyridamole and Myeloproliferative Disorders

ArticleYear
[Association of hemorrhagic and thrombotic phenomena in myeloproliferative syndromes].
    Medicina, 1981, Volume: 41 Suppl

    Topics: Adult; Aspirin; Blood Platelet Disorders; Dipyridamole; Female; Humans; Leukemia, Myeloid; Male; Mid

1981
PF 4 versus beta TG as evidence for platelet activation in myeloproliferative disorders.
    Scandinavian journal of haematology, 1985, Volume: 35, Issue:3

    Topics: Adult; Age Factors; Aged; Aspirin; Beta-Globulins; beta-Thromboglobulin; Dipyridamole; Female; Human

1985